CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer
Running, not enrolling
Conditions studied: Bladder Cancer, Cancer of the Bladder, Recurrent, Non-muscle Invasive Bladder Cancer
In brief
Bladder cancer is the most common urinary tract cancer and the 5th most common cancer in the US (1). Yet bladder cancer research is underfunded relative to other common cancers. As a result, bladder cancer care is prone to evidence gaps that produce decision uncertainty for both patients and clinicians. The Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) for Bladder Cancer Study has the potential to fill these critical evidence gaps, change care pathways for the management of non-muscle-invasive bladder cancer (NMIBC), and provide for personalized, patient-centered care. The purpose of CISTO is to conduct a large prospective study that directly compares the impact of medical management versus bladder removal in recurrent high-grade NMIBC patients with Bacillus Calmette-Guerin (BCG) failure on clinical outcomes and patient and caregiver experience using standardized patient-reported outcomes (PROs).
Key facts
- Study ID
- NCT03933826
- Run by
- University of Washington
- People needed
- 570
- Starts
- 2019-07-09
- Expected to finish
- 2029-06-30
- Last updated by the study team
- 2026-05-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States
- Mayo Clinic Cancer Center — Phoenix, Arizona, United States
- USC/Norris Comprehensive CA Center — Los Angeles, California, United States
- UCLA — Los Angeles, California, United States
- Hoag Memorial Hospital Presbyterian — Newport Beach, California, United States
- University of Colorado Anschutz Medical Campus — Aurora, Colorado, United States
- University of Miami — Miami, Florida, United States
- H. Lee Moffitt Cancer Center & Research Institute — Tampa, Florida, United States
- Emory University — Atlanta, Georgia, United States
- University of Chicago — Chicago, Illinois, United States
- University of Iowa — Iowa City, Iowa, United States
- University of Kansas Medical Center — Kansas City, Kansas, United States
- LSU Healthcare Network - Multi Specialty Clinic — Metairie, Louisiana, United States
- Johns Hopkins University, School of Medicine — Baltimore, Maryland, United States
- Chesapeake Urology Research Associates — Hanover, Maryland, United States
- Brigham and Women's Hospital — Boston, Massachusetts, United States
- Michigan Medicine Rogel Cancer Center — Ann Arbor, Michigan, United States
- Spectrum Health — Grand Rapids, Michigan, United States
- Comprehensive Urology -- A Division of Michigan Healthcare Professionals — Royal Oak, Michigan, United States
- Albert Einstein College of Medicine — The Bronx, New York, United States
- University of North Carolina — Chapel Hill, North Carolina, United States
- Levine Cancer Institute — Charlotte, North Carolina, United States
- The Ohio State University — Columbus, Ohio, United States
- Stephenson Cancer Center — Oklahoma City, Oklahoma, United States
- Asante Rogue Regional Medical Center — Medford, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.